These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 15784651)
1. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651 [TBL] [Abstract][Full Text] [Related]
2. Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells. Roychowdhury S; Vyas PM; Svensson CK Drug Metab Dispos; 2007 Apr; 35(4):676-81. PubMed ID: 17220235 [TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes. Vyas PM; Roychowdhury S; Woster PM; Svensson CK Biochem Pharmacol; 2005 Jul; 70(2):275-86. PubMed ID: 15894292 [TBL] [Abstract][Full Text] [Related]
4. Detection of haptenated proteins in organotypic human skin explant cultures exposed to dapsone. Roychowdhury S; Cram AE; Aly A; Svensson CK Drug Metab Dispos; 2007 Sep; 35(9):1463-5. PubMed ID: 17553916 [TBL] [Abstract][Full Text] [Related]
5. Role of human cyclooxygenase-2 in the bioactivation of dapsone and sulfamethoxazole. Vyas PM; Roychowdhury S; Svensson CK Drug Metab Dispos; 2006 Jan; 34(1):16-8. PubMed ID: 16214851 [TBL] [Abstract][Full Text] [Related]
6. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases. Vyas PM; Roychowdhury S; Koukouritaki SB; Hines RN; Krueger SK; Williams DE; Nauseef WM; Svensson CK J Pharmacol Exp Ther; 2006 Oct; 319(1):497-505. PubMed ID: 16857727 [TBL] [Abstract][Full Text] [Related]
7. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450. Vyas PM; Roychowdhury S; Khan FD; Prisinzano TE; Lamba J; Schuetz EG; Blaisdell J; Goldstein JA; Munson KL; Hines RN; Svensson CK J Pharmacol Exp Ther; 2006 Oct; 319(1):488-96. PubMed ID: 16857728 [TBL] [Abstract][Full Text] [Related]
8. Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts. Bhaiya P; Roychowdhury S; Vyas PM; Doll MA; Hein DW; Svensson CK Toxicol Appl Pharmacol; 2006 Sep; 215(2):158-67. PubMed ID: 16603214 [TBL] [Abstract][Full Text] [Related]
9. Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes. Khan FD; Roychowdhury S; Nemes R; Vyas PM; Woster PM; Svensson CK Toxicology; 2006 Feb; 218(2-3):90-9. PubMed ID: 16289751 [TBL] [Abstract][Full Text] [Related]
10. Effect of arylhydroxylamine metabolites of sulfamethoxazole and dapsone on stress signal expression in human keratinocytes. Khan FD; Vyas PM; Gaspari AA; Svensson CK J Pharmacol Exp Ther; 2007 Dec; 323(3):771-7. PubMed ID: 17766678 [TBL] [Abstract][Full Text] [Related]
11. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600 [TBL] [Abstract][Full Text] [Related]
12. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions. Reilly TP; Woster PM; Svensson CK J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831 [TBL] [Abstract][Full Text] [Related]
13. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals? Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253 [TBL] [Abstract][Full Text] [Related]
15. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation. Callan HE; Jenkins RE; Maggs JL; Lavergne SN; Clarke SE; Naisbitt DJ; Park BK Chem Res Toxicol; 2009 May; 22(5):937-48. PubMed ID: 19358516 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study. Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433 [TBL] [Abstract][Full Text] [Related]
17. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes. Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605 [TBL] [Abstract][Full Text] [Related]
18. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884 [TBL] [Abstract][Full Text] [Related]
19. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055 [TBL] [Abstract][Full Text] [Related]